TY  - JOUR
AU  - Ribeiro, Marcelo C
AU  - Rivera-Arbelaez, Jose M
AU  - Cofiño-Fabres, Carla
AU  - Schwach, Verena
AU  - Slaats, Rolf H
AU  - Ten Den, Simone A
AU  - Vermeul, Kim
AU  - van den Berg, Albert
AU  - Perez-Pomares, Jose M
AU  - Segerink, Loes I
AU  - Guadix, Juan A
AU  - Passier, Robert
PY  - 2022
DO  - 10.3390/jpm12020214
SN  - 2075-4426
UR  - http://hdl.handle.net/10668/21372
T2  - Journal of personalized medicine
AB  - Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human in vitro models for studying heart disease and for drug safety screening. Nevertheless, their associated immaturity relative to the adult myocardium...
LA  - en
KW  - cardiac performance
KW  - contractile force
KW  - engineered heart tissues
KW  - hPSC-CMs
KW  - serum-free
KW  - versatile platform
KW  - Myocytes, cardiac
KW  - Isoproterenol
KW  - Nifedipine
KW  - Triiodothyronine
KW  - Insulin-like growth factor I
KW  - Myocardium
KW  - Pluripotent stem cells
KW  - Electric stimulation
KW  - Physical functional performance
KW  - Dexamethasone
KW  - Heart diseases
KW  - Dexametasona
KW  - Estimulación eléctrica
KW  - Factor I del crecimiento similar a la insulina
KW  - Isoproterenol
KW  - Miocardio
KW  - Miocitos cardíacos
KW  - Nifedipino
KW  - Rendimiento físico funcional
KW  - Triyodotironina
TI  - A New Versatile Platform for Assessment of Improved Cardiac Performance in Human-Engineered Heart Tissues.
TY  - research article
VL  - 12
ER  -